STOCK TITAN

Kathryn Romano sells 12,500 KRYS shares (NASDAQ: KRYS); 750 more vest

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Kathryn Romano reported sales and an intended sale of KRYS common stock. The filing shows 12,500 common shares were sold on 02/09/2026 for $3,401,705.00. It also lists 750 restricted shares tied to vesting as compensation on 02/27/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did Kathryn Romano report in the KRYS Form 144?

Kathryn Romano reported a disposition of 12,500 common shares on 02/09/2026 for $3,401,705.00. The filing also lists 750 restricted shares associated with vesting on 02/27/2026 as compensation.

How many KRYS shares were sold in the past three months?

The filing shows a sale of 12,500 common shares on 02/09/2026 with an aggregate amount of $3,401,705.00. This figure is reported under "Securities Sold During The Past 3 Months."

What securities are listed as to be sold for KRYS?

The filing lists 750 common shares described as "Restricted Stock Vesting" tied to compensation with an effective date of 02/27/2026. The entry is shown under "Securities To Be Sold."

Through which broker or account is the KRYS sale noted?

The entry references Fidelity Brokerage Services LLC at the address shown and lists 750 in connection with that broker. The filing pairs the broker line with the restricted-share entry dated 02/27/2026.

Does the KRYS Form 144 show additional cash or pricing details?

Yes; the sale of 12,500 shares on 02/09/2026 is shown with an aggregate amount of $3,401,705.00. No per-share price or further proceeds allocation is provided in the excerpt.
Krystal Biotech

NASDAQ:KRYS

KRYS Rankings

KRYS Latest News

KRYS Latest SEC Filings

KRYS Stock Data

8.08B
24.97M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
PITTSBURGH